Table: begin end state 1 11 non-cytoplasmic 12 31 transmembrane 32 59 cytoplasmic 60 83 transmembrane 84 88 non-cytoplasmic 89 109 transmembrane 110 137 cytoplasmic 138 157 transmembrane 158 174 non-cytoplasmic 175 194 transmembrane 195 202 cytoplasmic 203 224 transmembrane 225 229 non-cytoplasmic 230 255 transmembrane 256 293 cytoplasmic 294 315 transmembrane 316 338 non-cytoplasmic 339 360 transmembrane 361 375 cytoplasmic 376 393 transmembrane 394 398 non-cytoplasmic 399 422 transmembrane 423 483 cytoplasmic
Input: >Pf6N2E2_4086 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_4086 MLEVINDFLSGKVLIVLIVGLGSYFTIRSRFVQFRHFFHMFTVFRDSLKSSTDQLSSFQA LMLSLAGRVGAGNIAGVGIAVTLGGPGAVFWMWVTALVGMSSSFFECSLGQLYKRCDSEG QFRGGPSYYIQHGLQKRWLGMIMAFLLLVTFGFAFNGLQAHAVTHSLNNAFGFDTTYTGL GLAVLLGLVFIGGIKRIAKVADLLVPVKTLAYIAVTIYVIVLQFDHVPAMLATIVKSAFG LDQAFGGLIGSAIVMGVKRGVFANEAGLGSAPNVAAVASVEHPVAQGVVQAFSVFLDTFV ICTCTALLILLSGFYTPGFEGDGIALTQNSLAAVVGDWGRMFISVALALFVFTSILYNYY LGENNLRFMLGENRKALIAYRALVLVLIFWGAIENLSTVFAFADITMTLLAFVNLIALFL LFKVGMRILRDYDDQRSAGIKTPVFDSSKFPDLDLDRKAWPASPSAPVAKPDAAVAGATA AQR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server